详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Epidemiology of dietary iron deficiency in China from 1990 to 2021: findings from the global burden of disease study 2021

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China. [2]School of Pharmacy, North China University of Science and Technology, Tangshan, Hebei, China. [3]Department of Medical Affairs, Xuanwu Hospital Capital Medical University, Changchun Street 45, Xicheng District, Beijing, 100053, China.

出处：

DOI：

关键词： Dietary iron deficiency Prevalence Disability adjusted life years Burden of disease Trend

摘要：

To analyze the burden of dietary iron deficiency in China from 1990 to 2021.Using the results of the 2021 Global Burden of Disease (GBD 2021) study, this study analyzed the prevalence and disability adjusted life years (DALY) of dietary iron deficiency in China from 1990 to 2021.In 2021, the prevalence number of dietary iron deficiency was 795,910,75 (76,187,661-82,382,158), which decreased by 40.86% compared to that in 1990. The number of DALY were 1,689,209 (1,119,315-2,445,991), which decreased by 47.15% compared to that in 1990. The age-standardized prevalence rate (ASPR) and age-standardized DALY rate (ASDR) of dietary iron deficiency showed a downward trend from 1990 to 2021 (P < 0.05).From 1990 to 2021, the burden of dietary iron deficiency in China showed a downward trend, with the burden of females having a significantly higher than males, and the burden in females aged 20 to 49 years old increases significantly.© 2025. The Author(s).

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2024]版：

无

最新[2023]版：

大类 | 2 区

医学

小类 | 2 区公共卫生、环境卫生与职业卫生

第一作者：

第一作者机构： [1]National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021 [2]Burden of epilepsy in China and its provinces, 1990 to 2019: findings from the Global Burden of Disease Study 2019 [3]Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022 [4]A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China. [5]Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [6]Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019 [7]Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition [8]Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From the Global Burden of Disease Study 2019 [9]Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019. [10]1990-2010年中国病毒性肝炎的疾病负担及变化趋势